The global market for Epinephrine Autoinjectors was estimated at US$2.5 Billion in 2023 and is projected to reach US$3.6 Billion by 2030, growing at a CAGR of 4.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Epinephrine Autoinjectors Market]( "Epinephrine Autoinjectors Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the The 0.15 gm Dosage Epinephrine Autoinjectors segment, which is expected to reach US$2.5 Billion by 2030 with a CAGR of 4.6%. The 0.30 gm Dosage Epinephrine Autoinjectors segment is also set to grow at 5.6% CAGR for the next 8-year period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $756.1 Million in 2023, and China, forecasted to grow at an impressive 4.5% CAGR to reach $634.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Epinephrine Autoinjectors Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Epinephrine Autoinjectors Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Epinephrine Autoinjectors Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as ALK-Abello A/S, Bausch + Lomb UK Ltd- Emerade, Teva Pharmaceutical Industries Ltd., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 44 Featured):
- ALK-Abello A/S
- Bausch + Lomb UK Ltd- Emerade
- Teva Pharmaceutical Industries Ltd.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
- Epinephrine Autoinjectors - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Epinephrine Autoinjectors Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- Table 2: World Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 3: World Historic Review for Epinephrine Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 4: World 16-Year Perspective for Epinephrine Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 6: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 7: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 8: World Recent Past, Current & Future Analysis for Individuals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 9: World Historic Review for Individuals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 10: World 16-Year Perspective for Individuals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 11: World Recent Past, Current & Future Analysis for 0.15 gm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 12: World Historic Review for 0.15 gm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 13: World 16-Year Perspective for 0.15 gm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 14: World Recent Past, Current & Future Analysis for 0.30 gm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 15: World Historic Review for 0.30 gm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 16: World 16-Year Perspective for 0.30 gm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 17: World Recent Past, Current & Future Analysis for 0.5 gm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 18: World Historic Review for 0.5 gm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 19: World 16-Year Perspective for 0.5 gm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
UNITED STATES
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 20: USA Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 21: USA Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 22: USA 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 23: USA Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 24: USA Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 25: USA 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
CANADA
- Table 26: Canada Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 27: Canada Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 28: Canada 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 29: Canada Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 30: Canada Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 31: Canada 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
JAPAN
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 32: Japan Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: Japan Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 34: Japan 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 35: Japan Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 36: Japan Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 37: Japan 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
CHINA
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 38: China Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 39: China Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 40: China 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 41: China Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 42: China Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 43: China 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
EUROPE
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 44: Europe Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 45: Europe Historic Review for Epinephrine Autoinjectors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 46: Europe 16-Year Perspective for Epinephrine Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 47: Europe Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 48: Europe Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 49: Europe 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 51: Europe Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 52: Europe 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
FRANCE
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 53: France Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 54: France Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 55: France 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 56: France Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: France Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 58: France 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
GERMANY
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 59: Germany Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 60: Germany Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 61: Germany 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 62: Germany Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: Germany Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 64: Germany 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
ITALY
- Table 65: Italy Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 66: Italy Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 67: Italy 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 68: Italy Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 69: Italy Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 70: Italy 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 71: UK Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 72: UK Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 73: UK 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 74: UK Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 75: UK Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 76: UK 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 77: Rest of Europe Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 78: Rest of Europe Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 79: Rest of Europe 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 80: Rest of Europe Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 81: Rest of Europe Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 82: Rest of Europe 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Epinephrine Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 84: Asia-Pacific Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 85: Asia-Pacific 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 87: Asia-Pacific Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 88: Asia-Pacific 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
REST OF WORLD
- Table 89: Rest of World Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 90: Rest of World Historic Review for Epinephrine Autoinjectors by End-Use - Hospitals & Clinics and Individuals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 91: Rest of World 16-Year Perspective for Epinephrine Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Individuals for the Years 2014, 2024 & 2030
- Table 92: Rest of World Recent Past, Current & Future Analysis for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 93: Rest of World Historic Review for Epinephrine Autoinjectors by Dosage - 0.15 gm, 0.30 gm and 0.5 gm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 94: Rest of World 16-Year Perspective for Epinephrine Autoinjectors by Dosage - Percentage Breakdown of Value Sales for 0.15 gm, 0.30 gm and 0.5 gm for the Years 2014, 2024 & 2030
Companies Mentioned
- ALK-Abello A/S
- Bausch + Lomb UK Ltd- Emerade
- Teva Pharmaceutical Industries Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | December 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.5 Billion |
| Forecasted Market Value ( USD | $ 3.6 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 3 |
